Skip to main content
HOUSE 789116th CongressReferred to the Subcommittee on Health.

Improving Transparency and Accuracy in Medicare Part D Spending Act

Last Action
3/1/2019

Actions

  • 2019-03-01Referred to the Subcommittee on Health.
  • 2019-01-25Referred to the Subcommittee on Health.
  • 2019-01-24Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2019-01-24Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2019-01-24Introduced in House
  • 2019-01-24Introduced in House

CRS Summary

As of 2019-01-24 (00)

Improving Transparency and Accuracy in Medicare Part D Spending Act

This bill prohibits Medicare prescription drug plan sponsors from retroactively reducing payment on clean claims submitted by pharmacies. (A "clean claim" is a Medicare claim that is free of defects such as incomplete documentation.)

Cosponsors (3)

  • Earl Carter (R-GA)
  • Doug Collins (R-GA)
  • Cathy Rodgers (R-WA)

Subjects

  • Medicare
  • Prescription drugs
Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.